Hee-Je Kim, M.D. Ph.D.
Korean J Hematol 2012; 47(1): 1-2Ki Woong Sung, M.D. Ph.D.
Korean J Hematol 2012; 47(1): 3-5Jae Wook Kim, Su-Jin Shin, and Chan-Jeoung Park
Korean J Hematol 2012; 47(1): 6So Young Kim, You La Jeon, and Tae Sung Park
Korean J Hematol 2012; 47(1): 7Erin-Siobhain R. Currin, and Ajay K. Gopal
Korean J Hematol 2012; 47(1): 8-16Thanh-Nhan Nguyen-Pham, Youn-Kyung Lee, Hyun-Ju Lee, Mi-Hyun Kim, Deok-Hwan Yang, Hyeoung-Joon Kim, and Je-Jung Lee
Korean J Hematol 2012; 47(1): 17-27Hyeon Jin Park, Eun-Hye Park, Kyu-Won Jung, Hyun-Joo Kong, Young-Joo Won, Joo Young Lee, Jong Hyung Yoon, Byung-Kiu Park, Hyewon Lee, Hyeon-Seok Eom, and Sohee Park
Korean J Hematol 2012; 47(1): 28-38Sang Hyuk Park, Seongsoo Jang, Hyoeun Shim, Geum-Borae Park, Chan-Jeoung Park, Hyun-Sook Chi, and Sang-Bum Hong
Korean J Hematol 2012; 47(1): 39-43Keun Wook Bae, Bo Eun Kim, Kyung Nam Koh, Ho Joon Im, and Jong Jin Seo
Korean J Hematol 2012; 47(1): 44-52Jeong Eun Kim, Dok Hyun Yoon, Geundoo Jang, Dae Ho Lee, Shin Kim, Chan-Sik Park, Jooryung Huh, Won Seog Kim, Jinny Park, Jae Hoon Lee, Soon Il Lee, and Cheolwon Suh
Korean J Hematol 2012; 47(1): 53-59
Profile of the phase I and phase II trials.
|@|~(^,^)~|@|